Drugs / Trimbow
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | TRIMBOW | — | 2026-05-14 | fda.gov ↗ |
| Approved | EU (EMA) | Trimbow | — | 2017-07-17 | europa.eu ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05495698 | Dec 2022 → Dec 2026 expected | chronic obstructive pulmonary disease | Franciscus Gasthuis | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimbow | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05495698 ↗ |
| Route | Inhaled | “single-inhaler triple therapy (Trimbow)” NCT05495698 ↗ |